SEC Form 4 · accession 0000899243-16-022937
Dicerna Pharmaceuticals Inc · DRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis Langer
Director
Period of report
Jun 14, 2016
Accepted (ET)
Jun 15, 2016 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001399529
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F1 | $3.26 | Jun 14, 2016 | A | 15,000 | A | — | Jun 14, 2026 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The option vests in full on June 14, 2017 subject to the Reporting Person's continued service to the Issuer through such date.